Search

everythinglearnresearchcommunity

for

Search:↓

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Histone modification is key in treating chronic inflammatory skin diseases.

New cytokine-targeted therapies show promise for treating alopecia areata.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

New technologies help us better understand how skin microbes affect skin diseases.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

RDW can be a useful marker for inflammation in alopecia areata patients.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.